Radioactive Stent Used for Cancer Treatments Market

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Radioactive Stent Used for Cancer Treatments Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Radioactive Stent Used for Cancer Treatments Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Radioactive Stent Used for Cancer Treatments Market, Segmentation by Type
   1. Introduction
      1. Market Size and Forecast, Segmentation by Type
   2. I125 Isotope
      1. Market Size and Forecast, By Region
   3. I131 Isotope-Iodine
      1. Market Size and Forecast, By Region
10. Radioactive Stent Used for Cancer Treatments Market, Segmentation by Application
    1. Introduction
       1. Market Size and Forecast, Segmentation by Application
    2. Esophageal Cancer
       1. Market Size and Forecast, By Region
    3. Biliary Cancer
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       2. U.S.
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       3. Canada
    3. Europe
       1. Market Size and Forecast
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       2. U.K.
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       3. Germany
       4. France
       5. Spain
       6. Italy
       7. Russia
       8. Nordic
       9. Benelux
       10. Rest of Europe
    4. APAC
       1. Market Size and Forecast
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       2. China
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       3. Korea
       4. Japan
       5. India
       6. Australia
       7. Singapore
       8. Taiwan
       9. South East Asia
       10. Rest of Asia-Pacific
    5. Middle East and Africa
       1. Market Size and Forecast
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       2. UAE
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       3. Turky
       4. Saudi Arabia
       5. South Africa
       6. Egypt
       7. Nigeria
       8. Rest of MEA
    6. LATAM
       1. Market Size and Forecast
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       2. Brazil
          1. Segmentation by Type
             1. I125 Isotope
             2. I131 Isotope-Iodine
          2. Segmentation by Application
             1. Esophageal Cancer
             2. Biliary Cancer
       3. Mexico
       4. Argentina
       5. Chile
       6. Colombia
       7. Rest of LATAM
12. Competitive Landscape, 2023
    1. Introduction
    2. Radioactive Stent Used for Cancer Treatments Market Share Analysis, 2023 (%)
       1. Market Share Analysis, 2023
       2. Competition Ranking, 2023
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. Micro-Tech
       1. Business Overview
       2. Financial Data
       3. Key Product Categories
       4. Recent Developments
    2. Changzhou Zhiye
    3. Changzhou Garson
    4. Lepu Medical
    5. Braun
    6. Fude
    7. Degania Medical
    8. Biotronik
    9. Balton